SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-021212
Filing Date
2023-05-11
Accepted
2023-05-11 16:06:12
Documents
13
Period of Report
2023-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bcab-20230511.htm   iXBRL 8-K 55427
2 EX-99.1 bcab-ex99_1.htm EX-99.1 164636
  Complete submission text file 0000950170-23-021212.txt   347906

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bcab-20230511_lab.xml EX-101.LAB 12806
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bcab-20230511.xsd EX-101.SCH 2466
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bcab-20230511_pre.xml EX-101.PRE 9451
7 EXTRACTED XBRL INSTANCE DOCUMENT bcab-20230511_htm.xml XML 4516
Mailing Address 11085 TORREYANA ROAD SAN DIEGO CA 92121
Business Address 11085 TORREYANA ROAD SAN DIEGO CA 92121 858-558-0708
BioAtla, Inc. (Filer) CIK: 0001826892 (see all company filings)

IRS No.: 851922320 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39787 | Film No.: 23910952
SIC: 2836 Biological Products, (No Diagnostic Substances)